Gene body methylation can alter gene expression and is a therapeutic target in cancer. - Wikidata - awgldk - TriplyDB

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

http://www.wikidata.org/entity/Q34471361

about

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes Lipopolysaccharide (LPS) disrupts particle transport, cilia function and sperm motility in an ex vivo oviduct model.Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Site-specific methylation changes in the glucocorticoid receptor exon 1F promoter in relation to life adversity: systematic review of contributing factors.DNA methylation changes in epithelial ovarian cancer histotypes.Genetic and Epigenetic Alterations in Bladder Cancer Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Genome-wide and single-base resolution DNA methylomes of the Pacific oyster Crassostrea gigas provide insight into the evolution of invertebrate CpG methylation.Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.DNA Methylation Profiles of Blood Cells Are Distinct between Early-Onset Obese and Control Individuals.Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia.Body-hypomethylated human genes harbor extensive intragenic transcriptional activity and are prone to cancer-associated dysregulation Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment.Integrated Analysis of DNA Methylation and mRNA Expression Profiles to Identify Key Genes in Severe Oligozoospermia Modeling complex patterns of differential DNA methylation that associate with gene expression changes.Chemotherapy-induced hypomethylation of N-myc downstream-regulated gene 4 in the bone marrow of patients with acute myeloid leukemia.DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing.Expression of regulatory factor X1 can predict the prognosis of breast cancer HSPs drive dichotomous T-cell immune responses via DNA methylome remodelling in antigen presenting cells.CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2'-deoxycytidine.TET proteins and the control of cytosine demethylation in cancer.DNA methylation dynamics in muscle development and disease.Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.The potential role of DNA methylation in abdominal aortic aneurysms.Distinct roles of DNMT1-dependent and DNMT1-independent methylation patterns in the genome of mouse embryonic stem cells Genome-Wide DNA Methylation Patterns of Bovine Blastocysts Developed In Vivo from Embryos Completed Different Stages of Development In Vitro.Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers.cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.Deep sequencing and de novo assembly of the mouse oocyte transcriptome define the contribution of transcription to the DNA methylation landscape Epigenetics in lung fibrosis: from pathobiology to treatment perspective.Aberrant DNA Methylation in Keratoacanthoma.Site-Dependent Differences in DNA Methylation and Their Impact on Plant Establishment and Phosphorus Nutrition in Populus trichocarpa Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines.

P2860

Q24170431-ADA6A6C1-CFD3-4E07-9F53-907B73542067 Q26767183-BB874AC5-C2A6-4028-AA8A-E3471B1358B6 Q27321142-EF9DDD2E-3BF7-433F-9ECC-DE344A7F414C Q27323950-76D78486-53D3-4781-8E38-436C4410AE93 Q27687075-AEF2FC79-0D7F-4B84-A06C-9BF05C149231 Q27690722-EA751089-DDB4-4AF8-B676-98DA5BA5EC2B Q28074732-A0FF8693-8F7B-4B47-9A4B-918A424C344A Q28087759-AD1AB1B9-B1D9-455D-B47C-115E08407132 Q30633120-924961EC-2420-483C-BE43-BF1952D33DE6 Q30659867-54C4ED25-D677-44F8-9F3D-B9E31ABEFA52 Q30826635-8F1FA2C4-E486-4135-B2FA-A0004D8A766D Q31035683-06AA8F8A-DA21-4305-8FC9-6500426E8A17 Q33559098-106A3475-B707-450F-B775-4D687C053A94 Q33624604-75941218-078D-4E10-8C25-EAEE74F43992 Q33635817-D28FA2A7-9896-4C96-B1DA-639CCC2FD3B3 Q33654322-6DD9050B-2658-428D-B468-684CC1795D7C Q33665569-245E33D4-A4D8-4F94-BDE3-1D18FEDA643A Q33701597-B2C757F8-2298-4829-8ADC-D0C019386EE4 Q33707331-185A20D2-152F-4341-B50B-9732B980C5D4 Q33737466-8C6550AA-CAB3-44F8-8694-1ECA49B3A9C8 Q33741082-D746A53B-96A0-4822-876E-F18DD5989FE8 Q33751079-5247A09C-C124-4F1C-A532-804FA5E64C46 Q33766735-1E63A895-A1EA-4819-94B1-0F078E49E31A Q33836737-15B6BE23-6520-42DF-A6CF-EB9659706334 Q34547465-92C36EF4-3FCA-456F-BAEB-CDC44F77F1F3 Q34619389-C5E8C73F-BD96-4272-8412-281B5A4A7B90 Q34781073-014D5307-6616-4409-907B-4B1B24B42FF1 Q35021377-F43EC58C-99F9-4C63-87B8-F4265BF8C731 Q35149910-8A1E7A7A-0E0A-42D8-9656-705148427097 Q35585074-E90629F6-1F87-4A17-896A-4D525B924AFD Q35723702-04104BB5-3C5A-403E-9B9D-EAFEA7B1AA71 Q35760936-08B5FE84-26B4-44CA-A8EE-4BDED2CF373B Q35832315-34E70533-6C48-402F-96F9-D3869B91C9CB Q35858677-B26BE1AB-BD9F-4AF1-AACF-DD2FA1FB71D9 Q36066334-BFB5AA62-28A7-4E85-86B3-3DB27BC5EF61 Q36092232-16219D5C-223B-4EC8-A6A8-3525AF7B3568 Q36119163-683BBA08-7F55-4C75-BCFC-AE11265F4947 Q36176290-32864201-A3B7-4108-B648-EB3DBA825129 Q36228335-7B0CED66-87C0-431D-887D-DEA53B6562E1 Q36268784-13F65C10-6024-4E48-8A67-4D3FAD436DE7

P2860

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

http://www.wikidata.org/entity/Q34471361

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@ast

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@en

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@nl

type

label

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@ast

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@en

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@nl

prefLabel

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@ast

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@en

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

@nl

P1433

Q34471361-A4234BE5-F2A6-4114-8562-683D26BC1167

P1476

Q34471361-F7D18658-4B37-4882-B9A8-6ECB9C69BC85

P2093

Q34471361-2242C800-519B-4958-A854-F77B4F24D8C5

Q34471361-886C35B9-E03D-450B-9E67-9117C6063A0D

Q34471361-9244E6D4-2E90-4782-B4EB-6534A5196610

Q34471361-DCF42F9E-B5EE-41E5-A729-7C4A4A2299EA

Q34471361-F5C980DF-FF61-4FD2-A269-B1FFE2652F60

P2860

Q34471361-02356D79-29D6-49C2-930B-374BB4FA88C9

Q34471361-0DA391B9-1986-4F0E-AE77-B0BF157E7283

Q34471361-0E7A7D1B-2942-4D49-A985-835F875D77A9

Q34471361-10AE173B-FE81-4C6D-ADE6-F9427C7B8A68

Q34471361-111B1979-4D3F-49C3-A327-2ABEDDA99410

Q34471361-125099B8-A066-424C-A82A-0053348B3162

Q34471361-12AE8B60-7C70-463A-BF76-DDF01B2F5BEA

Q34471361-142911A0-EB6E-4386-88F5-269317641B02

Q34471361-153F295F-7079-4B9D-8E1E-01138E3CF49F

Q34471361-159915D9-5F45-41AC-B51B-1C227295FF88

P304

Q34471361-A79B0A58-6DA6-424E-A29F-444E29380477

P31

Q34471361-3A3A5DE5-F96A-418E-B773-334DBFC2457F

P356

Q34471361-75E9F4D6-6BA5-4DED-87A0-3C45CBCEB255

P433

Q34471361-CD94E842-E3E9-4400-B5DB-D811403E50F3

P478

Q34471361-4CCD8D26-8B1C-4994-AFB0-DECFAF908413

P50

Q34471361-659DF2BB-9D94-4A89-BE5B-B722D24A9EEF

P577

Q34471361-81DE46DF-90A5-499E-8390-BCA95077F326

P5875

Q34471361-5661612D-9ECD-44AF-9313-82E6CEAB4BA5

P698

Q34471361-8BEF2969-C851-439E-8A5C-C987255F477A

P932

Q34471361-AAEEACF5-E701-47B3-8160-1E97BD4121EF

P356

J.CCR.2014.07.028

P1433

P1476

Gene body methylation can alter gene expression and is a therapeutic target in cancer

@en

P2093

Daniel D De Carvalho

http://www.w3.org/2001/XMLSchema#string

Fides D Lay

http://www.w3.org/2001/XMLSchema#string

Han Han

http://www.w3.org/2001/XMLSchema#string

Peter A Jones

http://www.w3.org/2001/XMLSchema#string

Xiaojing Yang

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated encyclopedia of DNA elements in the human genome

Hallmarks of Cancer: The Next Generation

A decade of exploring the cancer epigenome - biological and translational implications

Epigenetics in alternative pre-mRNA splicing

DNA methylation screening identifies driver epigenetic events of cancer cell survival

Human DNA methylomes at base resolution show widespread epigenomic differences

Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes.

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

P304

577-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.07.028

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266082012

http://www.w3.org/2001/XMLSchema#string

P698

25263941

http://www.w3.org/2001/XMLSchema#string

P932

4224113

http://www.w3.org/2001/XMLSchema#string